A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers

Affiliations

¹ Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada. Electronic address: kboycott@cheo.on.ca.
² Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
³ Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
⁴ Human Genome Sequencing Center, Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.
⁵ Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁶ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
⁷ Illumina, Madison, WI, USA; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
⁸ Victor Chang Cardiac Research Institute, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
⁹ Microsoft Research, Seattle, Washington, USA.
¹⁰ Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
¹¹ Department of Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
¹² Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, CA, USA; DOE Joint Genome Institute, CA, USA; The University of California at Merced, CA, USA.
¹³ Faculty of Health and Medical Sciences, University of Western Australia Medical School, Perth, WA, Australia; Western Australian Register of Developmental Anomalies, Genetic Services of Western Australia, Perth, WA, Australia; Office of Population Health Genomics, Western Australian Department of Health, Perth, WA, Australia.

PMID: 30901545
DOI: 10.1016/j.cell.2019.02.040

Free article

A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers

Kym M Boycott et al. Cell. 2019.

Free article

. 2019 Mar 21;177(1):32-37.

doi: 10.1016/j.cell.2019.02.040.

Authors

Affiliations

¹ Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada. Electronic address: kboycott@cheo.on.ca.
² Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
³ Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
⁴ Human Genome Sequencing Center, Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX, USA.
⁵ Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁶ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
⁷ Illumina, Madison, WI, USA; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
⁸ Victor Chang Cardiac Research Institute, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
⁹ Microsoft Research, Seattle, Washington, USA.
¹⁰ Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
¹¹ Department of Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
¹² Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, CA, USA; DOE Joint Genome Institute, CA, USA; The University of California at Merced, CA, USA.
¹³ Faculty of Health and Medical Sciences, University of Western Australia Medical School, Perth, WA, Australia; Western Australian Register of Developmental Anomalies, Genetic Services of Western Australia, Perth, WA, Australia; Office of Population Health Genomics, Western Australian Department of Health, Perth, WA, Australia.

PMID: 30901545
DOI: 10.1016/j.cell.2019.02.040

Abstract

The introduction of exome sequencing in the clinic has sparked tremendous optimism for the future of rare disease diagnosis, and there is exciting opportunity to further leverage these advances. To provide diagnostic clarity to all of these patients, however, there is a critical need for the field to develop and implement strategies to understand the mechanisms underlying all rare diseases and translate these to clinical care.

PubMed Disclaimer

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers

Affiliations

A Diagnosis for All Rare Genetic Diseases: The Horizon and the Next Frontiers

Authors

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical